// App-Quantinova.ai

: Differential Production of Cytokines in Response to FVIII in Hemophilia Patients Undergoing ITI: A Preliminary Analysis of a Multi‐center Longitudinal Study

Researchers

Presenter

  • D. Matino

Principal Investigators

  • G. Castaman

  • A.K.C. Chan

  • G. Di Minno

  • P. Giordano

  • M.E. Mancuso

  • E. Marchesini

  • F. Peyvandi

  • E. Santagostino

  • C. Santoro

  • M. Schiavulli

  • A. De Luca

  • M. Gargaro

  • P. Puccetti

  • F. Fallarino

  • A. Iorio

Medical Centers

  • McMaster University, Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada

  • University of Florence, Florence, Italy

  • Federico II University, Naples, Italy

  • University of Bari, Bari, Italy

  • Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca Granda, Ospedale Maggiore Policlinico, Milan, Italy

  • University of Perugia, Terni, Perugia, Italy

  • Umberto I University Hospital, Rome, Italy

  • Santobono ‐ Pausilipon Hospital, Napoli, Italy

Locations

  • Canada

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • Alpha-1-microglobulin/bikunin precursor

  • Peripheral blood mononuclear cell

  • Cytokine

Drug/Treatment

  • FVIII

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved